Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Cisplatin and Oral Etoposide in Metastatic Ewing's Sarcoma
NCT00014313Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2001
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, etoposide in Ewing sarcoma, primitive neuroectodermal tumor (PNET), sponsored by European Organisation for Research and Treatment of Cancer. Started Jan 2001; status: terminated.
02
Drugs
cisplatinetoposide
03
Conditions
Ewing sarcomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00014313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014313.